CompletedNot Applicable

Prostatic Cancer Versus Androgen Deficiency

France1,614 participantsStarted 2013-06-03

Plain-language summary

Open study to make a comparison between hypogonadism and euogonadism patients regarding the severity of prostate cancer. The purpose of this study is to determine the importance of the relationship between the hormonal status and the type of the tumor at the time of surgical intervention as well as follow up of the patients.

Who can participate

Age range18 Years

SexMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Male patients over than 18 years of age, with localized, stage I or II prostate cancer, not receiving local treatment (radiation, phototherapy, thermotherapy,…) or hormonal therapy, showing indication of radical prostatectomy. Exclusion Criteria: * Absence of radical prostatectomy indication * Patient received local or hormonal therapy prior to surgery * Patients already enrolled in other clinical study incompatible with the study * Patients on a treatment which can affect hormonal level (Prednisone, Ketoconazole, Abiraterone, Finasteride, Dutasteride)

What they're measuring

Testosteron Serum level

Timeframe: The day prior to surgery

Gleason score

Timeframe: 5 years

Trial details

NCT IDNCT02235142

SponsorHopital Foch

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2016-06-27

View on ClinicalTrials.gov More Cancer of Prostate trials